FATAL SEPSIS FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN ADMINISTRATION FOR BLADDER-CANCER

被引:105
作者
RAWLS, WH
LAMM, DL
LOWE, BA
CRAWFORD, ED
SAROSDY, MF
MONTIE, JE
GROSSMAN, HB
SCARDINO, PT
机构
[1] UNIV BAYLOR,DEPT UROL,HOUSTON,TX
[2] UNIV OREGON,HLTH SCI CTR,DEPT UROL,EUGENE,OR 97403
[3] UNIV COLORADO,DEPT UROL,DENVER,CO 80202
[4] UNIV TEXAS,HLTH SCI CTR,DEPT UROL,SAN ANTONIO,TX 78284
[5] CLEVELAND CLIN EDUC FDN,DEPT UROL,CLEVELAND,OH 44106
[6] UNIV MICHIGAN,MED CTR,DEPT UROL,ANN ARBOR,MI 48109
关键词
D O I
10.1016/S0022-5347(17)39731-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Intravesical administration of bacillus Calmette-Guerin has been shown to be highly effective treatment of superficial bladder cancer. Complications from bacillus Calmette-Guerin therapy are usually minor but serious and even fatal reactions can occur. Five recent cases illustrate the gravity of bacillus Calmette-Guerin sepsis. One man with severe debility and the organic brain syndrome died acutely with a fever of 40°C. Two men had frank sepsis that progressed to multiorgan failure and death. Sepsis progressed despite the use of isoniazid, rifampin and streptomycin. Two men who had equally progressive sepsis with intravesical bacillus Calmette-Guerin survived with the use of cycloserine for the first 72 hours of treatment. Triple anticuberculous antibiotics, including cycloserine, may be lifesaving. Sepsis resulted from intravenous absorption through inflamed or disrupted urothelium. Bacillus Calmette-Guerin treatment should not be administered in the presence of severe cystitis or after grossly traumatic catheterization.
引用
收藏
页码:1328 / 1330
页数:3
相关论文
共 11 条
[1]   COMPLICATIONS OF BCG VACCINATION IN NEOPLASTIC DISEASE [J].
AUNGST, CW ;
SOKAL, JE ;
JAGER, BV .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (05) :666-669
[2]   BCG AND CANCER .1. [J].
BAST, RC ;
ZBAR, B ;
BORSOS, T ;
RAPP, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (25) :1413-1420
[3]   EXPERIENCE WITH BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER-CARCINOMA [J].
BROSMAN, SA .
JOURNAL OF UROLOGY, 1982, 128 (01) :27-30
[4]   IMMUNOTHERAPY OF MURINE TRANSITIONAL CELL-CARCINOMA [J].
LAMM, DL ;
REICHERT, DF ;
HARRIS, SC ;
LUCIO, RM .
JOURNAL OF UROLOGY, 1982, 128 (05) :1104-1108
[5]   COMPLICATIONS OF BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY IN 1,278 PATIENTS WITH BLADDER-CANCER [J].
LAMM, DL ;
STOGDILL, VD ;
STOGDILL, BJ ;
CRISPEN, RG .
JOURNAL OF UROLOGY, 1986, 135 (02) :272-274
[6]  
LEE TS, 1973, RAPID QUANTITATIVE M
[7]  
Lotte A, 1984, Adv Tuberc Res, V21, P194
[8]  
PINSKY C, 1973, NATL CANCER I MONOGR, V39, P225
[9]   SERUM TRANSAMINASE ELEVATIONS AND OTHER HEPATIC ABNORMALITIES IN PATIENTS RECEIVING ISONIAZID [J].
SCHARER, L ;
SMITH, JP .
ANNALS OF INTERNAL MEDICINE, 1969, 71 (06) :1113-+
[10]  
SPARKS FC, 1975, SURG FORUM, V26, P162